NCT02153723View on ClinicalTrials.gov

Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone)

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

January 31, 2016

Conditions
Rett Syndrome
Interventions
DRUG

Glatiramer Acetate

Trial Locations (1)

10467

Montefiore Medical center, The Bronx

All Listed Sponsors
collaborator

Rett Syndrome Research Trust

OTHER

lead

Montefiore Medical Center

OTHER

NCT02153723 - Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone) | Biotech Hunter | Biotech Hunter